Complete FXN records can avoid repeat genetic testing
Send the full molecular report before travel. If the diagnosis is already secure, the center may focus on staging and management instead of repeating broad genetic panels.
Skyclarys review creates medication and monitoring costs
Omaveloxolone is EU-authorised from age 16. Specialist review includes eligibility, current medicines, interaction risk and laboratory monitoring; recurring drug costs should not be mixed with the initial consultation quote.
Cardiology can be a major separate component
ECG, echocardiography, cardiac MRI or rhythm monitoring may be required according to the patient's history and findings. These investigations should be scoped individually.
Metabolic surveillance is targeted
Glucose/HbA1c and other laboratory testing are relevant because diabetes and treatment-related monitoring may affect care. Testing should follow the clinical question rather than a fixed package.
Rehabilitation and equipment are recurring costs
Physiotherapy, occupational therapy, speech therapy, orthotics and mobility devices often continue long term and may be delivered partly in the home country after the German plan is defined.
Orthopedic review is separate from routine neurology
Scoliosis, foot deformity or contracture evaluation can add imaging, orthotics and surgical consultation only when clinically relevant.
Clinical trials should be costed separately from approved treatment
Gene-based and other experimental approaches remain research. Sponsor-covered study procedures, screening and travel are different from standard-care estimates.
Send records before asking for an estimate
A center can define the scope more accurately after reviewing diagnosis, treatment status and multisystem complications.
- Complete FXN genetic report
- Ataxia/neurology clinic records
- Current functional assessments
- Cardiology records
- Glucose/HbA1c and relevant laboratory results
- Current medication including Skyclarys
- Liver monitoring if on omaveloxolone
- Orthopedic and rehabilitation reports
- Exact request: diagnosis review, Skyclarys, cardiac risk, rehabilitation, genetics or trial inquiry
Official sources
Last source-reviewed 2026-09-02. Cost procedures and published service fees can change, so confirm current terms directly with the provider before transferring money or booking travel.